Diffuse astrocytoma, MYB- or MYBL1-altered, is classified as CNS WHO grade 1 with favorable prognosis, with a reported 5-year event-free survival rate of 100% in cases with near-total resection [20]. This evidence concerns the gene MYBL1 and diffuse astrocytoma.